Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abingdon and Birmingham Uni set up Dx joint venture

This article was originally published in Clinica

Executive Summary

Diagnostics specialist Abingdon Health has teamed up with the UK’s University of Birmingham to launch a new company, Bioscience Ventures. The joint venture will develop diagnostic products, based on intellectual property originating from the university, in areas such as cancer, genetic diseases, infectious diseases, drug testing and veterinary applications. Bioscience, which will be based at the university's campus in Edgbaston and trade through its subsidiary company Alta Bioscience, will also provide a variety of services such as analysis and synthesis of DNA, protein and other biochemicals to clients both on and off campus in the pharmaceutical and food industries.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel